Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
12/2005
12/01/2005WO2005095345A3 Heteroaryl guanidines as inhibitors of viral replication
12/01/2005WO2004101544A8 Benzyl sulfonamide derivatives as androgen receptor antagonists
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267098 Modulators of cellular adhesion
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005CA2567483A1 Pyrazinylmethyl lactam derivatives
11/2005
11/30/2005EP1599470A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
11/30/2005EP1599454A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments
11/30/2005EP1458381B1 Triazoles as oxytocin antagonists
11/30/2005CN1229371C Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/29/2005US6969730 Amines as histamine-3 receptor ligands and their therapeutic applications
11/29/2005US6969611 Methods to prepare cells comprising heterologous polyketide synthase expression systems
11/29/2005CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain
11/29/2005CA2244245C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/24/2005WO2005110988A1 Pyridone compounds as inhibitors of bacterial type iii protein secretion systems
11/24/2005WO2005082856A3 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/24/2005US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050260274 Preparation of nanoparticles
11/24/2005US20050260273 Applicatin of a bioactive agent in a solvent composition to produce a target particle morphology
11/24/2005CA2564325A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
11/23/2005EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/23/2005EP1597238A1 Hiv replication inhibiting pyrimidines and triazines
11/23/2005EP1596656A2 Pyrazoles and methods of making and using the same
11/23/2005EP0871760B1 Recombinant production of novel polyketides
11/22/2005CA2180445C Chemical switching of taxo-diterpenoids between low solubility active forms and high solubility inactive forms
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005107742A1 Novel antiviral helioxanthin analogs
11/17/2005WO2005070427A8 Compounds for the sustained reduction of body weight
11/17/2005WO2004096208A9 Composition for oral administration containing alkylene dioxybenzene derivative
11/17/2005US20050256322 Deprotecting and cyclizing an optionally substituted 3-(dioxolan-4-yl)-2-tetrahydrofuranol with hydrochloric acid, sulfuric acid, phosphoric acid, methanesulfonic acid, p-toluenesulfonic acid, or a strong acidic ion-exchange resin to form 3-hydroxyhexahydrofuro(2,3-b)furan
11/17/2005US20050256137 Pyridone compounds as inhibitors of bacterial type III protien secreation systems
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1594847A2 Substituted azole derivatives as therapeutic agents
11/16/2005EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/15/2005US6965041 N-acylphosphoramidites and their use in oligonucleotide synthesis
11/15/2005CA2179640C Watersoluble azole antifungals
11/10/2005WO2005105075A1 Tri-substitued 2-benzhydryl-5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives
11/10/2005WO2005084365A3 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
11/10/2005US20050250946 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
11/10/2005CA2563161A1 Tri-substitued 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstited pyran derivatives
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/08/2005US6962938 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
11/03/2005WO2002004440A9 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
11/03/2005US20050245514 Novel physiologically active substances
11/02/2005EP1591441A1 Carboxylic acid compounds
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1005493B1 Antiviral protease inhibitors
11/02/2005CN1692108A Pesticidal heterocycles
11/02/2005CN1692100A 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl]benzamide derivatives and their use for the treatment of pain spinal injuries or gastrointestinal disorders
11/01/2005CA2072915C Vitamin d compound, method of preparing this compound and intermediate therefor
10/2005
10/27/2005WO2005100335A1 Stereoselective synthesis of certain trifluoromethyl-substituted oxiranes
10/27/2005US20050240035 polymerase inhibitors such as -1-(5-Cyano-pyridin-2-yl)-3-(1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea, used as antiviral agents
10/27/2005US20050239874 Novel analgesic and immunomodulatory cannabinoids
10/27/2005US20050239691 Cross-linked glycopeptide - cephalosporin antibiotics
10/26/2005EP1589018A1 Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same
10/26/2005EP1587585A1 Acylsulfonamide compounds as inhibitors of rna-dependent rna (viral) polymerases
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1427408A4 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE)
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005US20050234250 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
10/20/2005US20050234238 8-(Biaryl)quinoline pde4 inhibitors
10/20/2005US20050234121 coating formulations and polymers that utilize a dioxanone containing composition or fatty acid derivative
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/19/2005EP1585725A2 Compounds which mimic the chemical and biological properties of discodermolide
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005CN1684956A Total synthesis of myriaporones
10/19/2005CN1684948A Cytotoxic agents containing novel potent taxanes and their therapeutic use
10/18/2005CA2460970C Processes for preparing crystalline and amorphous mupirocin calcium
10/18/2005CA2190129C Therapeutic phenoxyalkylpyridazines and intermediates therefor
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/13/2005WO2005095378A2 Vegetable based dioxanone derivatives, synthesis and uses thereof
10/13/2005WO2005095345A2 Heteroaryl guanidines as inhibitors of viral replication
10/13/2005WO2005058812A3 Prostaglandin synthesis
10/13/2005WO2004071447A9 Substituted azole derivatives as therapeutic agents
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005CA2560776A1 Vegetable based dioxanone derivatives, synthesis and uses thereof
10/12/2005EP1313749B1 Process for preparation of anhydrous azithromycin
10/12/2005EP0954522B1 Novel substituted naphthopyrans
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/06/2005WO2005092884A1 Novel crystalline forms of conazoles and methods of making and using the same
10/06/2005WO2005092324A1 Ginkgolide compounds, compositions, extracts, and uses thereof
10/06/2005WO2004072031A8 Phenylacetamides and their use as glucokinase modulators
10/06/2005US20050222124 Benzenesulfonamide derivatives as antipsychotic agents
10/05/2005EP1581207A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/05/2005CN1678620A Macrolide compounds endowed with antiinflammatory activity
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1221539C Taxane derivs
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005CA2152771C 7-o-ethers of taxane derivatives
09/2005
09/29/2005WO2005090501A1 Reactive coalescent agents
09/29/2005WO2005090337A1 Opioid receptor antagonists
09/29/2005WO2005089745A1 Salvinorin derivatives and uses thereof
09/29/2005WO2005089549A1 Use of epoxides as fungicides
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 120